Live Breaking News & Updates on Hidenburg Research Feb

Stay updated with breaking news from Hidenburg research feb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Limiting SPAC-Related Litigation Risk: Disclosure And Process Considerations | Goodwin


INTRODUCTION
2020 marked an incredible surge in the prevalence of Special Purpose Acquisition Company (“SPAC”) initial public offerings and business combinations (“deSPAC transactions”). In 2020, there were 248 SPAC IPOs (raising total gross proceeds of over $83 billion) and 66 deSPAC transactions, as compared with 2019’s 59 SPAC IPOs (raising approximately $13.6 billion in gross proceeds) and 28 deSPAC transactions.
[1] And the pace continues to skyrocket in 2021 with 160 SPAC IPOs in the first two months of the year and 13 completed deSPAC transactions.
[2] This spectacular rise, and the related profits, has unsurprisingly garnered attention from both the United States Securities and Exchange Commission (“SEC”) and plaintiffs’ law firms. Most recently, the SEC’s Division of Corporation Finance released guidance ....

New York , United States , Cayman Islands , Purpose Acquisition Company , Fletcher Corp , Nikola Corp , Clover Health Investments , Hindenburg Research , Capital Hedosophia Holdings Corp , Hidenburg Research Feb , Division Of Corporation , Lancadia Holdings Inc , Department Of Justice , See Ap Services , Exchange Act Sections , Exchange Commission , Clover Health , Greenland Acquisition Corp , Immunovant Inc , Special Purpose Acquisition Company , United States Securities , Corporation Finance , Exchange Act , Acquisition Corp , General Motors , Social Capital Hedosophia Holdings ,